Structure (Spironolactone 01)
Spironolactone Tablet, Film Coated
Product Images NDC 63629-1093
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63629-1093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Spironolactone 02)
Figure 2 (Spironolactone 03)
This appears to be a table or chart with various data points related to diabetes, including measurements for creatinine and potassium levels, as well as information on beta blockers and the effectiveness of spironolactone compared to a placebo. However, without additional context or labels for the various columns and rows, it is difficult to provide a more specific or useful description.*
Lbl636291093
Spironolactone Tablets, USP 100 mg is a medication that comes in tablet form. Each tablet contains 100 mg of Spironolactone, USP. This medication should be kept out of children's reach and stored at 20° to 25°C (68° to 77°F). Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. NILD is possibly the name of the company that produced this medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
